Cardiac contractility modulation therapy in advanced systolic heart failure

被引:0
作者
Alexander R. Lyon
Michael A. Samara
David S. Feldman
机构
[1] NIHR Cardiovascular Biomedical Research Unit,
[2] Royal Brompton Hospital,undefined
[3] Minneapolis Heart Institute,undefined
[4] Abbott Northwestern Hospital,undefined
[5] Georgia Insitute of Technology,undefined
[6] Morehouse School of Medicine,undefined
来源
Nature Reviews Cardiology | 2013年 / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac contractility modulation has positive inotropic effects in the failing heart, without increasing oxygen consumption. Here, Lyon and colleagues review the preclinical data, mode of action, and clinical evidence for the use of this therapy in patients with chronic heart failure. Long-term application of cardiac contractility modulation seems to improve exercise tolerance and quality of life, and have an acceptable safety profile.
引用
收藏
页码:584 / 598
页数:14
相关论文
共 108 条
[61]  
Askenazi J(2001)Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure J. Mol. Cell. Cardiol. 33 359-958
[62]  
Alexander JH(2007)Altered connexin expression in human congestive heart failure Eur. J. Heart Fail. 9 955-1380
[63]  
Koenigsberg DI(2008)First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: Clinical and technical aspects of combined therapies Europace 10 1375-1132
[64]  
Belic N(2011)Cardiac contractility modulation in non-responders to cardiac resynchronization therapy Eur. J. Heart Fail. 13 1126-1586
[65]  
Lesch M(2005)Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy Circulation 112 1580-474
[66]  
Lawo T(2012)Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy JAMA 308 465-2448
[67]  
Pappone C(2009)Effects of exercise training on depressive symptoms in patients with chronic heart failure: The HF-ACTION randomized trial N. Engl. J. Med. 361 2436-706
[68]  
Stix G(2012)Ferric carboxymaltose in patients with heart failure and iron deficiency Circulation 126 697-undefined
[69]  
Yu CM(undefined)High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi–dependent manner/clinical perspective undefined undefined undefined-undefined
[70]  
Zhang Q(undefined)undefined undefined undefined undefined-undefined